S 1090

Known as: S-1090 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2007
0119872007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Cefmatilen hydrochloride hydrate (S-1090) was administered at 500 and 1000 mg potency/kg once orally to beagle dogs. No deaths… (More)
Is this relevant?
2001
2001
Cefmatilen hydrochloride hydrate (S-1090), a new non-ester type of orally active cephem antibiotic synthesized in Shionogi… (More)
Is this relevant?
2001
2001
A nephrotoxicity study of Cefmatilen hydrochloride hydrate (S-1090) was conducted in rabbits at single oral doses of 250, 500 and… (More)
Is this relevant?
2001
2001
S-1090, a cefmatilen hydrochloride hydrate, is being developed as a cephalosporin antibiotic for oral use. Immunogenicity… (More)
Is this relevant?
2001
2001
A six-month repeated oral dose toxicity study of Cefmatilen hydrochloride hydrate (S-1090) at dose levels of 40, 100 and 250 mg… (More)
Is this relevant?
2001
2001
Cefmatilen hydrochloride hydrate (S-1090) was orally administered to rats at dose levels of 100, 300 and 1000 mg potency/kg once… (More)
Is this relevant?
2001
2001
Cefmatilen hydrochloride hydrate (S-1090) was administered daily by gavage to female rats at doses of 100, 300 or 1000 mg potency… (More)
Is this relevant?
1999
1999
Direct injection high-performance liquid chromatographic (HPLC) methods with column switching and UV detection were developed for… (More)
Is this relevant?
1995
1995
Purpose. Elucidating the transport characteristics of S-1090, a new orally active cephalosporin in rat small intestinal brush… (More)
Is this relevant?
1987
1987
S-1090 is a new synthetic, nonesterified, oral cephalosporin with a broad spectrum of antibacterial activity. The activities of S… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?